Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 1
2009 3
2010 3
2011 1
2012 9
2013 9
2014 7
2015 14
2016 8
2017 4
2018 18
2019 15
2020 11
2021 22
2022 18
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.
Solar Vasconcelos JP, Chen N, Titmuss E, Tu D, Brule SY, Goodwin R, Jonker DJ, Price T, Zalcberg JR, Moore MJ, Karapetis CS, Siu L, Shapiro J, Simes J, Gill S, O'Callaghan CJ, Loree JM. Solar Vasconcelos JP, et al. Among authors: karapetis cs. Clin Cancer Res. 2024 Mar 15;30(6):1121-1130. doi: 10.1158/1078-0432.CCR-23-3275. Clin Cancer Res. 2024. PMID: 38170586 Free PMC article.
Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
Jiang DM, Parshad S, Zhan L, Sim HW, Siu LL, Liu G, Shapiro JD, Price TJ, Jonker DJ, Karapetis CS, Strickland AH, Zhang W, Jeffery M, Tu D, Ng S, Sabesan S, Shannon J, Townsend A, O'Callaghan CJ, Chen EX. Jiang DM, et al. Among authors: karapetis cs. Clin Colorectal Cancer. 2023 Dec;22(4):457-463. doi: 10.1016/j.clcc.2023.08.006. Epub 2023 Aug 23. Clin Colorectal Cancer. 2023. PMID: 37704538 Free article. Clinical Trial.
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy.
M Naeini M, Newell F, Aoude LG, Bonazzi VF, Patel K, Lampe G, Koufariotis LT, Lakis V, Addala V, Kondrashova O, Johnston RL, Sharma S, Brosda S, Holmes O, Leonard C, Wood S, Xu Q, Thomas J, Walpole E, Tao Mai G, Ackland SP, Martin J, Burge M, Finch R, Karapetis CS, Shannon J, Nott L, Bohmer R, Wilson K, Barnes E, Zalcberg JR, Mark Smithers B, Simes J, Price T, Gebski V, Nones K, Watson DI, Pearson JV, Barbour AP, Waddell N. M Naeini M, et al. Among authors: karapetis cs. Nat Commun. 2023 May 31;14(1):3155. doi: 10.1038/s41467-023-38891-x. Nat Commun. 2023. PMID: 37258531 Free PMC article.
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.
Korver SK, Bowen JM, Gibson RJ, Ball IA, Secombe KR, Wain TJ, Logan RM, Tuke J, Mead KR, Richards AM, Karapetis CS, Keefe DM, Coller JK. Korver SK, et al. Among authors: karapetis cs. Cancer Chemother Pharmacol. 2023 Jun;91(6):507-521. doi: 10.1007/s00280-023-04538-3. Epub 2023 May 10. Cancer Chemother Pharmacol. 2023. PMID: 37162533 Free PMC article.
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial.
Gupta A, O'Callaghan CJ, Zhu L, Jonker DJ, Wong RPW, Colwell B, Moore MJ, Karapetis CS, Tebbutt NC, Shapiro JD, Tu D, Booth CM. Gupta A, et al. Among authors: karapetis cs. JCO Oncol Pract. 2023 Jun;19(6):e859-e866. doi: 10.1200/OP.22.00737. Epub 2023 Mar 7. JCO Oncol Pract. 2023. PMID: 36881786 Free PMC article. Clinical Trial.
131 results